Why the study?
Carotid atherosclerosis causes a great proportion of ischemic strokes, making early identification of unstable or vulnerable plaques to identify patients at high risk of significant medical and socioeconomical value.
Do serum biomarkers identify unstable carotid plaque in patients with carotid atherosclerosis?
Do serum biomarkers identify unstable carotid plaque in patients with carotid atherosclerosis?
Serum biomarkers may have a potential role in identifying unstable carotid plaques and patients at high risk for atheroembolic stroke.
Answers are grounded in this paper and cite their sources.
May refine stroke risk assessment in carotid atherosclerosis; leaves open prospective validation before clinical use.
Carotid atherosclerosis is responsible for a great proportion of ischemic strokes. Early identification of unstable or vulnerable carotid plaques, and therefore, of patients at high risk for stroke, is of significant medical and socioeconomical value. We reviewed the current literature and discussed the potential role of the most important serum biomarkers in identifying patients with carotid atherosclerosis who are at high risk for atheroembolic stroke.
No takes yet. Share an insight, caveat, or question.
Sofogianni et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: